BioSpace News Archive

Business

Sigma-Aldrich Corporation Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be $3.45 to

February 9, 2011
·
14 min read
Business

Talecris Biotherapeutics to Report Fourth Quarter and Full Year 2010 Financial Results

February 9, 2011
·
1 min read
Policy

LABS Inc. Regulatory and Quality Assurance

February 9, 2011
·
2 min read
Business

Dynatronics Corporation to Release Fiscal Second Quarter Results Monday, February 14, 2011; Conference Call Set for 1:30 p.m. ET

February 9, 2011
·
1 min read
Genetown

Cynosure, Inc. to Present at Citi 2011 Global Health Care Conference

February 9, 2011
·
1 min read
Business

Spherix to Present at the 13th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

February 9, 2011
·
3 min read
Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum

February 9, 2011
·
2 min read
Biotech Beach

Cadence Pharmaceuticals, Inc. to Present at Two Investment Conferences in February 2011

February 9, 2011
·
1 min read
Business

Genomic Health, Inc. Announces Year-End 2010 Financial Results, Provides 2011 Financial Outlook

February 9, 2011
·
11 min read
Business

Cyberonics Inc. to Report Fiscal Year 2011 Third Quarter Results and Host Conference Call on March 2, 2011

February 9, 2011
·
1 min read